Comparison of virus isolation using the Vero E6 cell line with real-time RT-PCR assay for the detection of human metapneumovirus
© Matsuzaki et al; licensee BioMed Central Ltd. 2010
Received: 4 December 2009
Accepted: 14 June 2010
Published: 14 June 2010
The use of cell culture for the diagnosis of human metapneumovirus (hMPV) infection is uncommon at present and molecular method such as reverse-transcription PCR (RT-PCR) has been widely and most commonly used as the preferred test. We aimed to compare the results of virus isolation using Vero E6 cells with real-time RT-PCR for the detection of hMPV, since such a comparison data is not available.
Between December 2007 and July 2008, we obtained 224 nasopharyngeal swab specimens from patients with acute respiratory infection and tested by the two methods.
Forty-three (19.2%) were found positive by cell culture and 62 (27.7%) by real-time RT-PCR. Cell cultures were positive for 42 of 62 specimens found positive by real-time RT-PCR (67.7% sensitivity) and for 1 of 162 specimens found negative by real-time RT-PCR (99.4% specificity), respectively. The sensitivity of the cell culture was 76.2-87.5% (mean 81.8%) when specimens were collected within 3 days after the onset of symptoms, and the sensitivity decreased to 50% or less thereafter. Among specimens collected within 3 days after symptom onset, all of the real-time RT-PCR positive specimens having a viral load of more than 1.25×105 copies/ml were found positive by cell culture.
Cell culture using Vero E6 cell line has 81.8% sensitivity compared with the real-time RT-PCR method, when specimens are collected within 3 days after the onset of symptoms. Thus, this method is a useful method for epidemiological and virological research even in facilities with minimal laboratory resources.
Human metapneumovirus (hMPV) was first described in 2001 following its isolation from nasopharyngeal specimens from infants and children with acute respiratory infection (ARI) in The Netherlands and it has been categorized as a member of the genus Metapneumovirus of the subfamily Pneumovirinae of the family Paramyxoviridae [1–3]. It has been recognized as an important agent responsible for respiratory tract disease worldwide, especially in the pediatric and elderly populations [2–5], with serological studies having revealed that hMPV seropositivity is almost universal by the age of 5 years [3, 6].
For laboratory diagnosis, the most definitive test is virus isolation by cell culture . Although hMPV isolation has commonly been performed using the LLC-MK2 or Vero cell lines, the growth of hMPV is slow and often requires several blind passages before any cytopathic effect (CPE) is apparent, particularly following primary isolation [1, 3–5, 7, 8]. Thus, it is believed that virus isolation is difficult, being possible in only one-third to one-half of cases in which nasopharyngeal samples are found to positive for hMPV by reverse-transcription PCR (RT-PCR) [2, 3, 5, 9]. The use of cell culture for the diagnosis of hMPV infection is uncommon at present and RT-PCR has been widely and most commonly used as the preferred test due to its sensitivity [2, 3]. In our previous study, we demonstrated that the infection efficiency of hMPV in Vero E6 cells was more than 5 to 20 times better than that in LLC-MK2 cells and, in fact, we succeeded in isolating nearly 100 strains between 2004 and 2006 using this cell line [6, 10, 11]. However, there is no data on the effectiveness of virus isolation in comparison with real-time RT-PCR for hMPV detection from clinical specimens, since virus isolation is not common. In this paper, we show the results of virus isolation from 224 clinical specimens using Vero E6 cells and the real-time RT-PCR method.
A total of 224 nasopharyngeal swab specimens were collected from patients who had been clinically diagnosed with ARI with fever and/or cough and/or rhinorrhea at 3 pediatric clinics in Yamagata and Sendai between December 2007 and July 2008, as described previously for the evaluation of a newly developed rapid antigen detection kit using immunochromatography compared with real-time RT-PCR . The specimens were collected and used for the previous and present studies, after getting the informed consent from the patients or their guardians. These studies were approved by the Institutional Review Board of Sendai Medical Center, National Hospital Organization Japan, on Feb. 29, 2008 (Reference No CHI-19-33). Of these specimens, 166 were from children aged under 5 years, 43 were from children aged between 5 and 9 years, 7 were from children aged between 10 and 15 years and 8 were from patients > 15 years. Each specimen was placed immediately in a tube containing 3 ml of transport medium [11, 12] and transported at 4°C to the Department of Microbiology, Yamagata Prefectural Institute of Public Health for virus isolation and real-time RT-PCR. Prior to specimen inoculation for virus isolation, 200 μl of the specimen was transferred to a 1.5 ml microtube and stocked at -80°C until application to real-time RT-PCR assay. Virus isolation was carried out by the 96-well modified microplate method including Vero E6 and other five cell lines [10, 11]. We observed the plates two or three times per week for CPEs for 4 weeks without passage or medium change . When a hMPV-like CPE was observed, second passage, identification and genotyping was carried out as described previously . The method and results of real-time RT-PCR assay with a TaqMan probe using an ABI Prism 7500 Fast real-time PCR system (Applied Biosystems) were described previously . Primers and a probe targeting the hMPV N gene were designed based on the reports of Maertzdorf et al.  and Bonroy et al. . Statistical analysis was performed by Fisher's exact probability test.
Comparison of virus isolation with real-time RT-PCR in hMPV detection
Days of specimen collection after onset of illness
No. of specimens
No. of specimens with the following resultsa:
Since the date of specimen collection is important, we should distinguish the data obtained at 1-3 days after the onset of symptoms from thereafter, when we compare virus isolation with real-time RT-PCR method. The sensitivity of virus isolation for specimens during this period was 76.2-87.5% (mean 81.8%). However, the sensitivity decreased for specimens collected on Day 4 and thereafter. This indicates that the excretion of hMPV infectious particles may decrease after 4 days from the onset of symptoms, which is in agreement with previous data for respiratory syncytial virus that indicates the predictive value of virus isolation is highest when respiratory specimens are collected 1-3 days after the onset of symptoms . Therefore, specimens for cell culture should be collected within three days after the onset of symptoms. The merit of real-time RT-PCR over cell culture rests in that it is able to detect hMPV genome with or without infectivity during this period. Since the two detection methods described here differ significantly in cost, turn-around-time and technical difficulty, we should use each method depending on the purpose.
Cell culture using Vero E6 cell line has approximately 80% sensitivity compared with the real-time RT-PCR method when specimens are collected within 3 days after the onset of symptoms. Along with its consistency in not producing false-positive results, cell culture using the Vero E6 cell line to be regarded as a useful method for epidemiological and virological research, through not for rapidly clinical diagnosis. Furthermore, this cell culture method might be applicable in facilities with minimal laboratory resources without expensive real-time RT-PCR system.
acute respiratory infection
This work was supported in part by Ohkura Pharmaceutical Co., Ltd. We also thank the medical staff and people of Yamagata Prefecture and of Miyagi Prefecture for their collaboration in specimen collection for the surveillance of viral infectious diseases.
- van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RAM, Osterhaus ADME: A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 2001, 7: 719-724. 10.1038/89098.View ArticlePubMedGoogle Scholar
- Kahn JS: Epidemiology of human metapneumovirus. Clin. Microbiol. Rev. 2006, 19: 546-557. 10.1128/CMR.00014-06.View ArticlePubMedPubMed CentralGoogle Scholar
- Collins PL, Crowe JE: Respiratory syncytial virus and metapneumovirus. Fields Virology. Edited by: Knipe DM, Howley PM. 2007, Philadelphia: Lippincott Williams & Wilkins, 2: 1601-1646. 5Google Scholar
- Falsey AR, Erdman D, Anderson LJ, Walsh EE: Human metapneumovirus infections in young and elderly adults. J. Infect. Dis. 2003, 187: 785-790. 10.1086/367901.View ArticlePubMedGoogle Scholar
- Williams JV, Harris PA, Tollefson SJ, Halburnt-Rush LL, Pingsterhaus JM, Edwards KM, Wright PF, Crowe JE: Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N. Engl. J. Med. 2004, 350: 443-450. 10.1056/NEJMoa025472.View ArticlePubMedPubMed CentralGoogle Scholar
- Matsuzaki Y, Itagaki T, Abiko C, Aoki Y, Suto A, Mizuta K: Clinical impact of human metapneumovirus genotypes and genotype-specific seroprevalence in Yamagata, Japan. J. Med. Virol. 2008, 80: 1084-1089. 10.1002/jmv.21194.View ArticlePubMedGoogle Scholar
- Boivin G, Abed Y, Pelletier G, Ruel L, Moisan D, Côté S, Peret TCT, Erdman DD, Anderson LJ: Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J. Infect. Dis. 2002, 186: 1330-1334. 10.1086/344319.View ArticlePubMedGoogle Scholar
- Peret TCT, Boivin G, Li Y, Couillard M, Humphrey C, Osterhaus ADME, Erdman DD, Anderson LJ: Characterization of human metapeumoviruses isolated from patients in North America. J. Infect. Dis. 2002, 185: 1660-1663. 10.1086/340518.View ArticlePubMedGoogle Scholar
- Ebihara T, Endo R, Ma X, Ishiguro N, Kikuta H: Detection of human metapneumovirus antigens in nasopharyngeal secretions by an immunofluorescent-antibody test. J. Clin. Microbiol. 2005, 43: 1138-1141. 10.1128/JCM.43.3.1138-1141.2005.View ArticlePubMedPubMed CentralGoogle Scholar
- Abiko C, Mizuta K, Itagaki T, Katsushima N, Ito S, Matsuzaki Y, Okamoto M, Nishimura H, Aoki Y, Murata T, Hoshina H, Hongo S, Ootani K: Outbreak of human metapneumovirus detected by use of the Vero E6 cell line in isolates collected in Yamagata, Japan, in 2004 and 2005. J. Clin. Microbiol. 2007, 45: 1912-1919. 10.1128/JCM.01251-06.View ArticlePubMedPubMed CentralGoogle Scholar
- Mizuta K, Abiko C, Aoki Y, Suto A, Hoshina H, Itagaki T, Katsushima N, Matsuzaki Y, Hongo S, Noda M, Kimura H, Ootani K: Analysis of monthly isolation of respiratory viruses from children by cell culture using a microplate method: a two-year study from 2004 to 2005 in Yamagata, Japan. Jpn. J. Infect. Dis. 2008, 61: 196-201.PubMedGoogle Scholar
- Matsuzaki Y, Takashita E, Okamoto M, Mizuta K, Itagaki T, Katsushima F, Katsushima Y, Nagai Y, Nishimura H: Evaluation of a new rapid antigen test using immunochromatography for detection of human metapneumovirus in comparison with real-time PCR assay. J. Clin. Microbiol. 2009, 47: 2981-2984. 10.1128/JCM.00321-09.View ArticlePubMedPubMed CentralGoogle Scholar
- Maertzdorf J, Wang CK, Brown JB, Quinto JD, Chu M, de Graaf M, van den Hoogen BG, Spaete R, Osterhaus ADME, Fouchier RAM: Real-time reverse transcriptase PCR assay for detection of human metapneumoviruses from all known genetic lineages. J. Clin. Microbiol. 2004, 42: 981-986. 10.1128/JCM.42.3.981-986.2004.View ArticlePubMedPubMed CentralGoogle Scholar
- Bonroy C, Vankeerberghen A, Boel A, De Beenhouwer H: Use of a multiplex real-time PCR to study the incidence of human metapneumovirus and human respiratory syncytial virus infections during two winter seasons in a Belgian paediatric hospital. Clin. Microbiol. Infect. 2007, 13: 504-509. 10.1111/j.1469-0691.2007.01682.x.View ArticlePubMedGoogle Scholar
- Wiedbrauk DL, Johnston SLG: Respiratory Syncytial Virus. Manual of clinical virology. New York: Raven Press, 1993: 184-195.
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/10/170/prepub